TransAlgae’s Oral Vaccination Solution for Wildlife and Farm Animals Challenges

TransAlgae’s Oral Vaccination Solution for Wildlife and Farm Animals Challenges

According to a new report published by Allied Market Research, titled, ”Animal Vaccines Market by Product Type and Animal Type: Global Opportunity Analysis and Industry Forecast, 2018 – 2025″, the global animal vaccines market accounted for $8,059 in 2017, and is estimated to reach $12,845 million by 2025, registering a CAGR of 5.9% from 2018 to 2025.

Animal vaccines are essential to ensure better animal health and welfare. Various vaccines such as attenuated vaccines, subunit vaccines, toxoid vaccines, and DNA vaccines help provide protection against multiple diseases, including rabies and foot & mouth disease. These vaccines offer cost-effective solutions instead of excessive antibiotic administration to treat such diseases.

The outbreak of epidemics results in severe mass wipeouts of animals and is a growing concern for the industries dependent on products obtained through farm animals. Moreover, zoonotic diseases that affect animals pose a threat to public health, hence avoiding transmission of such diseases via vaccination is a significant factor in disease management.

To date, however, effective and efficient oral vaccination delivery in animal health has been one of the veterinary sector’s biggest challenges. For wildlife animals, injectable vaccines are not practical and for farm animals, they are costly and involve heavy administration.

TransAlgae, an innovative Israeli biotech company that specializes in the research and development of a revolutionary algae-based delivery solves this major challenge by utilizing microalgae for two important purposes; A production site for the transferred sequence and a bio encapsulated delivery vehicle for the transcripted expressed molecule.

The Company has developed a disruptive oral delivery platform of drugs and pesticides for the benefit of the animal health and crop protection sectors. TransAlgae’s revolutionary green platform uses deactivated genetically modified (GMO-derived) algae to Orally deliver drugs such as vaccines and insecticides through powder or spray form.

The microalgae are produced without any antibiotics and in fermenters under a controlled environment enabling rapid, reproducibility low-cost production that can be practiced anywhere on the globe.

The emergence of new vaccines and delivery methods such as TransALgae’s greatly reduces the dependence on antimicrobial agents. Vaccination benefits us all – as it protects animal health and welfare, the livelihoods of those who work with livestock, as well as food security. In other words, Vaccination against specific diseases reduces the need to treat animals with antibiotics when they are sick.